Evaluating the Role of Colposcopy for Suspicious Cervical Conditions
Role Of Colposcopy In Evaluation Of Suspicious Cervix
This study is testing if colposcopy can help find early signs of cervical cancer in women aged 30 to 64 who have unusual cervical symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 53 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | Female |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06673680 on ClinicalTrials.gov |
What this trial studies
This study aims to correlate colposcopy findings with histopathological results in women with suspicious cervical lesions. It involves performing colposcopy and cervical punch biopsy to assess early detection of cervical precancer and invasive lesions. The study focuses on symptomatic women aged 30 to 64 years, evaluating various cervical abnormalities and their potential link to cervical cancer. By comparing the findings from colposcopy and biopsy, the study seeks to improve screening methods for cervical cancer.
Who should consider this trial
Good fit: Ideal candidates are women aged 30 to 64 with symptoms such as abnormal discharge or bleeding and clinically unhealthy cervix.
Not a fit: Patients who are pregnant, have active vaginal bleeding, or have undergone past treatments for cervical lesions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance early detection and treatment of cervical cancer, potentially saving lives.
How similar studies have performed: Other studies have shown success in using colposcopy for early detection of cervical cancer, indicating this approach is well-supported.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia Exclusion Criteria: * Pregnant women * Women having active vaginal bleeding. * Any past treatment for cervical lesions. * Women having frank growth of cervix. * Women who underwent a hysterectomy.
Where this trial is running
Sohag
- Sohag university Hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Omar K Mohamed, master
- Email: kamalo.omar@gmail.com
- Phone: +201022827251
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.